Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Takahiro Yoshida, Kideok Jin, Hong Song, Sunju Park, David L. Huso, Zhe Zhang, Han Liangfeng, Charles Zhu, Frank Bruchertseifer, Alfred Morgenstern, George Sgouros, Saraswati Sukumar
Published Apr 23, 2016 · Vol. 7, No. 22 · pp. 33306-33315
Hadi Tadayyon, Lakshmanan Sannachi, Mehrdad Gangeh, Ali Sadeghi-Naini, William Tran, Maureen E. Trudeau, Kathleen Pritchard, Sonal Ghandi, Sunil Verma, Gregory J. Czarnota
Published Apr 20, 2016 · Vol. 7, No. 29 · pp. 45094-45111
Marco Perez, Antonio Lucena-Cacace, Luis Miguel MarÃn-Gómez, Javier Padillo-Ruiz, Maria Jose Robles-Frias, Carmen Saez, Rocio Garcia-Carbonero, Amancio Carnero
Published Apr 20, 2016 · Vol. 7, No. 22 · pp. 33111-33124